Xeris Biopharma Holdings, Inc. (XERS) on GreekSoup https://greeksoup.ai/stocks/us/xers/ Every dated entry in the public record on Xeris Biopharma Holdings, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Xeris Biopharma Holdings, Inc.: short interest 8,027,654 shares at the 15 October 2026 settlement, 3.26 days to coverhttps://greeksoup.ai/stocks/us/xers/short-interest/us:XERS:short-interest:2026-10-15:04bffd4ae3Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/xers/filings/us:XERS:filing:2026-10-14:d7615bb461Wed, 14 Oct 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Pieper Steven (See Remarks) sold 5,000 shares (under a trading plan set in advance) at $9.41 on 1 October 2026, $47,036https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-10-02:12df050e86Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Mcculloch Kevin (See Remarks) sold 15,000 shares (under a trading plan set in advance) at $9.41 on 1 October 2026, $141,120https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-10-02:193bba4ce0Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Hecht Beth (See Remarks) sold 16,666 shares (under a trading plan set in advance) at $9.41 on 1 October 2026, $156,792https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-10-02:2dedd1eab1Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Form 144, BETH HECHT plans to sell 16,666 shares worth $159,327 around 1 October 2026https://greeksoup.ai/stocks/us/xers/planned-sales/us:XERS:planned-sale:2026-10-01:ce43acc477Thu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: short interest 7,202,379 shares at the 30 September 2026 settlement, 1.74 days to coverhttps://greeksoup.ai/stocks/us/xers/short-interest/us:XERS:short-interest:2026-09-30:3ccdeef0b9Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Mcculloch Kevin (See Remarks) sold 25,000 shares (under a trading plan set in advance) at $10.00 on 28 September 2026, $250,000https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-09-29:f5a5471b69Tue, 29 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Form 144, KEVIN MCCULLOCH plans to sell 70,000 shares worth $637,000 around 28 September 2026https://greeksoup.ai/stocks/us/xers/planned-sales/us:XERS:planned-sale:2026-09-28:06a1072085Mon, 28 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: short interest 8,058,977 shares at the 15 September 2026 settlement, 4.83 days to coverhttps://greeksoup.ai/stocks/us/xers/short-interest/us:XERS:short-interest:2026-09-15:a3f5ae3483Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/xers/filings/us:XERS:filing:2026-09-09:07aba82cecWed, 09 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Mcculloch Kevin (See Remarks) sold 15,000 shares (under a trading plan set in advance) at $8.49 on 1 September 2026, $127,308https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-09-01:87f7196d1dTue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Hecht Beth (See Remarks) sold 16,666 shares (under a trading plan set in advance) at $8.49 on 1 September 2026, $141,434https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-09-01:60ac9b4e6cTue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Pieper Steven (See Remarks) sold 5,000 shares (under a trading plan set in advance) at $8.50 on 1 September 2026, $42,500https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-09-01:09f6a9b362Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: short interest 8,041,258 shares at the 31 August 2026 settlement, 5.47 days to coverhttps://greeksoup.ai/stocks/us/xers/short-interest/us:XERS:short-interest:2026-08-31:3759a87dabMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: short interest 8,728,856 shares at the 14 August 2026 settlement, 4.44 days to coverhttps://greeksoup.ai/stocks/us/xers/short-interest/us:XERS:short-interest:2026-08-14:ffc0e47927Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Form 144, STEVEN PIEPER plans to sell 20,000 shares worth $167,800 around 12 August 2026https://greeksoup.ai/stocks/us/xers/planned-sales/us:XERS:planned-sale:2026-08-12:e61a8e6a78Wed, 12 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Pieper Steven (See Remarks) sold 5,000 shares (under a trading plan set in advance) at $8.50 on 12 August 2026, $42,500https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-08-12:9749df4fb7Wed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc. Q2 FY2026 results: revenue $92 million, net income -$31 millionhttps://greeksoup.ai/stocks/us/xers/results/fy2026-q2/us:XERS:result:2026-08-06:552f954193Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/xers/filings/us:XERS:filing:2026-08-06:dd3716e2e9Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/xers/filings/us:XERS:filing:2026-08-06:be827eedaaThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Mcculloch Kevin (See Remarks) sold 15,000 shares (under a trading plan set in advance) at $8.02 on 3 August 2026, $120,240https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-08-04:e546828e7eTue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Hecht Beth (See Remarks) sold 16,666 shares (under a trading plan set in advance) at $8.01 on 3 August 2026, $133,553https://greeksoup.ai/stocks/us/xers/insiders/us:XERS:insider:2026-08-04:b03a113407Tue, 04 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: Schedule 13G filed by Vanguard Capital Management, 5.0% of the classhttps://greeksoup.ai/stocks/us/xers/holders/us:XERS:schedule-13:2026-07-31:738ff439bbFri, 31 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Xeris Biopharma Holdings, Inc.: short interest 9,221,405 shares at the 31 July 2026 settlement, 6.75 days to coverhttps://greeksoup.ai/stocks/us/xers/short-interest/us:XERS:short-interest:2026-07-31:8d62465705Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>